ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Advanced Search

Comparison of Clinical Outcomes in Lung Transplant Patients with and without Preoperative Pulmonary Hypertension.

A. Kalya, M. Boga, S. Dasyam, R. Walia, M. Smith, R. Bremner, A. Omar, V. Patel, E. Kuo, J. Huang, S. Hashimi.

St. Joseph's Hospital and Medical Center, Phoenix.

Meeting: 2016 American Transplant Congress

Abstract number: B290

Keywords: Lung transplantation

Session Information

Date: Sunday, June 12, 2016

Session Name: Poster Session B: Lung Transplantation Posters

Session Time: 6:00pm-7:00pm

 Presentation Time: 6:00pm-7:00pm

Location: Halls C&D

Related Abstracts
  • Lung Transplant Patients With Elevated Baseline Pulmonary Arterial Pressures Are More Likely to Recover from Post-Transplant Acute Kidney Injury
  • Epidemiologic Change in Pulmonary Hypertension Patients Referred for Lung Transplantation Post Lung Allocation Score Implementation

Purpose: End-stage lung disease patients (pts) who undergo lung transplantation (LTx) with an elevated mean pulmonary artery pressure (mPAP) are known to have adverse outcomes. We performed a single-center, retrospective analysis of pts with and without elevated mPAP before LTx and looked at clinical outcomes and survival after LTx.

Methods: 65 pts underwent LTx (2012-2013). Preoperatively, 37 pts' mPAP was greater than 25 mm Hg (pulmonary hypertension [PH] group); 28 pts' mPAP was less than 25 mm Hg (control group). We compared baseline demographics, need for cardiopulmonary bypass, postoperative length of stay (LOS), days on ventilator support, readmissions after LTx, and up to 26 months follow-up. We also analyzed a subgroup of PH pts (n=21) with a higher mPAP (> 30 mm Hg) and a pulmonary vascular resistance > 3.4 Wood units, and analyzed outcomes compared to the control group using the same criteria as above. Using STATA statistical analysis software, we did group comparisons using chi-square and t-tests. A Cox regression model was used to calculate hazard rates for each group, and proportional survival was analyzed using Kaplan-Meier estimates. P-values ≤ 0.05 were considered statistically significant.

Results: mPAP and PVR were 32±10 mm Hg and 5.8±10, respectively, in the PH group and 18±3 mmHg and 2.0±1.0 in the control group. No significant differences in pt demographics were found between these groups. Outcomes are summarized in Table 1. There were no significant differences in need for bypass, LOS, ventilator support, or readmissions. No differences in the survival between the groups were noted up to 26 months' follow up. The subgroup with higher PH also showed no significant differences in survival or adverse outcomes.

Conclusion: Pts with PH who underwent LTx did not demonstrate adverse clinical outcomes after LTx. Larger pt sample and longer follow-up may shed further insight into this pt population.

Table 1. Outcomes among pts’ with and without PH undergoing LTx

     
  PH  (mPAP > 25 mm Hg)
n=37 
 Control (mPAP < 25 mm Hg)
n=28
p-value 
Cardiopulmonary bypass, n (%)  10 (27%)  6 (21%)  0.6
Ventilator after LTx (days)  1.7  1.9  0.5
LOS after LTx (days)  16.4  13.6  0.4
Readmission after LTx (n)  2.4  2.1  0.5
Deaths after LTx (up to 26 mo. follow-up)  9 (24.3%)  3(11%)  0.1

CITATION INFORMATION: Kalya A, Boga M, Dasyam S, Walia R, Smith M, Bremner R, Omar A, Patel V, Kuo E, Huang J, Hashimi S. Comparison of Clinical Outcomes in Lung Transplant Patients with and without Preoperative Pulmonary Hypertension. Am J Transplant. 2016;16 (suppl 3).

  • Tweet
  • Email
  • Print

To cite this abstract in AMA style:

Kalya A, Boga M, Dasyam S, Walia R, Smith M, Bremner R, Omar A, Patel V, Kuo E, Huang J, Hashimi S. Comparison of Clinical Outcomes in Lung Transplant Patients with and without Preoperative Pulmonary Hypertension. [abstract]. Am J Transplant. 2016; 16 (suppl 3). https://atcmeetingabstracts.com/abstract/comparison-of-clinical-outcomes-in-lung-transplant-patients-with-and-without-preoperative-pulmonary-hypertension/. Accessed March 6, 2021.

« Back to 2016 American Transplant Congress

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Role of Mitochondria, Metabolism and Inflammation: Pathways Influencing Short Term Outcomes Post-Renal Transplantation
    • Factors Influencing Creatinine Rise Following Donor Nephrectomy

    Visit Our Partner Sites

    American Transplant Congress (ATC)

    Visit the official site for the American Transplant Congress »

    American Journal of Transplantation

    The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

    American Society of Transplantation (AST)

    An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

    American Society of Transplant Surgeons (ASTS)

    The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

    Copyright © 2013-2021 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

    Privacy Policy

    loading Cancel
    Post was not sent - check your email addresses!
    Email check failed, please try again
    Sorry, your blog cannot share posts by email.
    This site uses cookies: Find out more.